Diagnosis of gynecological diseases, especially ovarian epithelial cancer

摘要

The present disclosure relates to methods and kits for diagnosing, predicting and / or monitoring gynecological diseases, particularly ovarian epithelial cancer, based on changes in the glycosylation pattern of CA125. More particularly, said change in glycosylation pattern relates to a change in glycosylation pattern recognizable by MGL.